New European investment fund, of 105 million euros, for medical innovations
European early stage companies developing biotechnologies and other such innovations in the medical field will be able to obtain new venture capital funding from a € 105 million investment fund, launched on Wednesday. The new funding will “focus on entrepreneurial innovation in therapies,” BioGeneration Ventures announced.